Click a link below to view the mailing archive as if it had been sent to you.
| 2025-01-31 12:15 | | AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing and more... |
| 2025-01-31 00:15 | | Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research and more... |
| 2025-01-30 12:15 | | Novo Nordisk commences fresh trials for CagriSema and more... |
| 2025-01-30 00:15 | | RFK Jr. denies being anti-vaccine during intense Senate confirmation and more... |
| 2025-01-29 12:15 | | How might the FDA evolve under RFK Jr. and Makary? and more... |
| 2025-01-29 00:15 | | Lawmakers report states shut out of Medicaid payment portals following Trump funding freeze and more... |
| 2025-01-28 12:15 | | Versant invests again in obesity, this time backing Helicore Biopharma and more... |
| 2025-01-28 00:15 | | CDC ordered to stop working with WHO immediately, upending expectations of an extended withdrawal and more... |
| 2025-01-27 12:15 | | Sage rejects Biogen's $469 million takeover offer, says offer undervalues company and more... |
| 2025-01-27 00:15 | | The biopharma industry outlook on 2025: Uncertainty and change and more... |
| 2025-01-24 12:15 | | Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11% and more... |
| 2025-01-24 00:15 | | Trump Administration Delays Funding To Cancer Research and more... |
| 2025-01-23 12:15 | | AI in medtech is taking off. Here are 4 trends to watch in 2025. and more... |
| 2025-01-23 00:15 | | Biogen research team hit by layoffs as company shifts resources to external opportunities and more... |
| 2025-01-22 12:15 | | Abbott's first-quarter profit forecast misses estimates, shares dip and more... |
| 2025-01-22 00:15 | | Large study of Novo, Lilly weight loss drugs shows decrease in risk of Alzheimer's and more... |
| 2025-01-21 12:15 | | FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment and more... |
| 2025-01-17 12:15 | | Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy and more... |
| 2025-01-17 00:15 | | Roche’s new deals head tries to navigate a more ‘complicated’ and ‘expensive’ biotech world and more... |
| 2025-01-16 12:15 | | The Rise of China Innovation in the Time of Trump and more... |
| 2025-01-16 00:15 | | JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole and more... |
| 2025-01-15 12:15 | | Under pressure to deal, Biogen executives deflect urgency at JPM25 and more... |
| 2025-01-15 00:15 | | JPM25: GSK, Sanofi CEOs welcome 'transparency' in response to anti-vaccine movement in US and more... |
| 2025-01-14 12:15 | | 5 questions facing emerging biotech in 2025 and more... |
| 2025-01-14 00:15 | | Novartis's U.S. patent for Entresto upheld by appeals court and more... |
| 2025-01-13 12:15 | | J&J to buy psychiatric drug developer Intra-Cellular for $14.6B and more... |
| 2025-01-10 12:15 | | 5 questions facing pharma in 2025 and more... |
| 2025-01-10 00:15 | | Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A and more... |
| 2025-01-09 12:15 | | Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex and more... |
| 2025-01-09 00:15 | | Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list and more... |
| 2025-01-08 12:15 | | Tenvie unveils with $200M and a neuro pipeline with assets from Denali and more... |
| 2025-01-08 00:15 | | Pharmaceuticals adding 'forever chemicals' to water supply and more... |
| 2025-01-07 12:15 | | After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter and more... |
| 2025-01-07 00:15 | | 5 FDA decisions to watch in the first quarter of 2025 and more... |
| 2025-01-06 12:15 | | CVS Health launches CostVantage model and more... |
| 2025-01-06 00:15 | | Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row and more... |
| 2025-01-03 12:15 | | Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open' and more... |
| 2025-01-02 12:15 | | 10 clinical trials to watch in the first half of 2025 and more... |
| 2025-01-02 00:15 | | Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver and more... |
